Tailoring of Rosuvastatin Calcium and Atenolol Bilayer Tablets for the Management of Hyperlipidemia Associated with Hypertension: A Preclinical Study
Sign Up to like & getrecommendations! Published in 2022 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics14081629
Abstract: Hyperlipidemia is still the leading cause of heart disease in patients with hypertension. The purpose of this study is to make rosuvastatin calcium (ROS) and atenolol (AT) bilayer tablets to treat coexisting dyslipidemia and hypertension… read more here.
Keywords: release layer; bilayer; bilayer tablets; release ... See more keywords
Formulation and Evaluation of Gastro-Bilayer Floating Tablets of Ezetimibe as Immediate Release Layer and Atenolol as Sustained Release Layer
Sign Up to like & getrecommendations! Published in 2019 at "Indian Journal of Pharmaceutical Education and Research"
DOI: 10.5530/ijper.53.2s.53
Abstract: Introduction: Combination therapy of ezetimibe and atenolol is highly desirable for better management of dyslipidaemia and hypertension. Ezetimibe has poor solubility hence variable and low bioavailability. Atenolol has poor absorption in lower gastrointestinal tract, short… read more here.
Keywords: release layer; layer; release; gastro bilayer ... See more keywords